Mariner Wealth Advisors »

Halozyme Therapeutics shares owned by Mariner Wealth Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mariner Wealth Advisors from 13F filings

Historical chart of Mariner Wealth Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Mariner Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Mariner Wealth Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 46k 36.96
2023-09-30 $2.2M 59k 38.20
2023-06-30 $2.6M 73k 36.07
2023-03-31 $3.0M 79k 38.19
2022-12-31 $4.7M 82k 56.90
2022-09-30 $3.3M 84k 39.54
2022-06-30 $471k 11k 44.04